In conclusion, systemic blockade of Hsp90 activity by STA-9090 significantly alleviated skin inflammation in mice with AD, as evidenced by lower disease activity, reduced epidermal hyperplasia or dermal leukocyte infiltration, and limited pruritus in animals. This evidence concerns the gene HSP90AA1 and dermatitis.